Data from the QUASAR long-term extension study demonstrate more than 70% of patients were in clinical remission and more than 40% of patients were in endoscopic remission at Week 92 SAN DIEGO, Calif.

43% of patients were in endoscopic remission. c Among patients achieving endoscopic improvement d at Week 44, 84% maintained endoscopic improvement through Week 92. Patients treated with TREMFYA ...

1 Patients treated with TREMFYA ® sustained clinical and endoscopic remission regardless of prior biologic and/or JAK inhibitor treatment history. "People living with ulcerative colitis seek ...

Immunosuppressants represent a second-line treatment option for refractory moderate-to-severe ulcerative colitis, particularly for patients who are either unresponsive to glucocorticoids or dependent ...

Cytomegalovirus (CMV) is a common herpes virus that is spread through body fluids such as saliva, tears, blood, urine, breast milk, semen, and vaginal fluids. More than half of all people have been ...

“There is a significant need for new ulcerative colitis therapies that offer meaningful improvements in symptoms and the promise of remission – both overall clinical remission and visible healing of ...

Ulcerative Colitis (UC) is a chronic inflammatory bowel ... imaging, lab tests, and an endoscopy, with key symptoms including bloody diarrhea, abdominal cramps, and urgent bowel movements.

Cytomegalovirus (CMV) is a ubiquitous herpesvirus that persists indefinitely after primary infection, usually in a latent form in various tissues (e.g., kidney, liver, lung). [1] One percent of ...

Darren Fletcher. Manchester United team coach and former midfielder Darren Fletcher was diagnosed with ulcerative colitis in 2011. In January 2013, he underwent surgery for the condition. David ...